Dr Daniel Kevin Storey, MD | |
8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 | |
(317) 745-5403 | |
Not Available |
Full Name | Dr Daniel Kevin Storey |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 14 Years |
Location | 8607 E Us Highway 36 Ste 100, Avon, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215252754 | NPI | - | NPPES |
201167100 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01072159A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hendricks Regional Health | Danville, IN | Hospital |
Iu Health West Hospital | Avon, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
American Health Network Of Indiana Llc | 9830093533 | 212 |
News Archive
At the health law's three-year mark, news outlets look ahead to the major provisions slated to take effect in 2014, exploring their impact on insurance premiums and who might be left uncovered.
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
Asthma affects more than 278 million people worldwide and can lead to serious consequences later in life. While current approved therapies address symptoms, they do not halt disease progression.
pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of IluvienĀ®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.
› Verified 1 days ago
Entity Name | American Health Network Of Indiana Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831236272 PECOS PAC ID: 9830093533 Enrollment ID: O20031124000691 |
News Archive
At the health law's three-year mark, news outlets look ahead to the major provisions slated to take effect in 2014, exploring their impact on insurance premiums and who might be left uncovered.
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
Asthma affects more than 278 million people worldwide and can lead to serious consequences later in life. While current approved therapies address symptoms, they do not halt disease progression.
pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of IluvienĀ®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Kevin Storey, MD 8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 Ph: (317) 745-5403 | Dr Daniel Kevin Storey, MD 8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 Ph: (317) 745-5403 |
News Archive
At the health law's three-year mark, news outlets look ahead to the major provisions slated to take effect in 2014, exploring their impact on insurance premiums and who might be left uncovered.
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
Asthma affects more than 278 million people worldwide and can lead to serious consequences later in life. While current approved therapies address symptoms, they do not halt disease progression.
pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of IluvienĀ®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.
› Verified 1 days ago
Ronald Stegemoller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5250 E Us Highway 36, Suite 610, Avon, IN 46123 Phone: 317-745-5403 Fax: 317-718-2180 | |
Dr. Wendy Allison Mason, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Ste. 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Mr. Eric D Clark, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8244 E Us Highway 36, Suite 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Amelia S Bruner, RN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7990 E Us Highway 36, Avon, IN 46123 Phone: 619-599-6637 | |
Charles H Tripple, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8244 E Us Highway 36, Suite 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Mark Benson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 8607 E Us Highway 36 Ste 100, Avon, IN 46123 Phone: 317-745-5403 |